相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The incidence and risk of infusion phlebitis with peripheral intravenous catheters: A meta-analysis
Luyu Lv et al.
JOURNAL OF VASCULAR ACCESS (2020)
In Vitro Activity of Fosfomycin in Double and Triple Combinations with Imipenem, Ciprofloxacin and Tobramycin Against Multidrug-Resistant Escherichia coli
Wael Mohamed Abu El-Wafa et al.
CURRENT MICROBIOLOGY (2020)
The pharmacodynamics of fosfomycin against Staphylococcus aureus studied in an in vitro model of infection
Alan Noel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Plasma and tissue pharmacokinetics of fosfomycin in morbidly obese and non-obese surgical patients: a controlled clinical trial (vol 74, pg 2335, 2019)
Christoph Dorn et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
Caifen Qi et al.
INFECTION AND DRUG RESISTANCE (2019)
Determination of the Dynamically Linked Indices of Fosfomycin for Pseudomonas aeruginosa in the Hollow Fiber Infection Model
Arnold Louie et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Pharmacokinetics and Pharmacodynamics of Fosfomycin and Its Activity against Extended-Spectrum-β-Lactamase-, Plasmid-Mediated AmpC-, and Carbapenemase-Producing Escherichia coli in a Murine Urinary Tract Infection Model
Ilya Nikolaevich Zykov et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers
R. A. Wijma et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Elucidation of the pharmacokinetic/ pharmacodynamic determinants of fosfomycin activity against Pseudomonas aeruginosa using a dynamic in vitro model
Hajira Bilal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
A fast and sensitive LC-MS/MS method for the quantification of fosfomycin in human urine and plasma using one sample preparation method and HILIC chromatography
Rixt A. Wijma et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers
E. Wenzler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Exploration of the Pharmacokinetic-Pharmacodynamic Relationships for Fosfomycin Efficacy Using an In Vitro Infection Model
Brian D. VanScoy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial Resistance
F. Docobo-Perez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
Dmitri Iarikov et al.
INFECTIOUS DISEASES AND THERAPY (2015)
High Activity of Fosfomycin and Rifampin against MethicillinResistant Staphylococcus aureus Biofilm In Vitro and in an Experimental Foreign-Body Infection Model
Raluca Mihailescu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Determination of susceptibility to fosfomycin and tigecycline of Enterobacteriaceae, particularly Escherichia coli isolates, producing extended-spectrum β-lactamases from multiple regional Canadian hospitals
Carlee Beuk et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2013)
Evaluation of fosfomycin activity against uropathogens in a fosfomycin-naive population in South India: a prospective study
Rani Diana Sahni et al.
FUTURE MICROBIOLOGY (2013)
In Vitro Activity of Fosfomycin against bla(KPC)-Containing Klebsiella pneumoniae Isolates, Including Those Nonsusceptible to Tigecycline and/or Colistin
Andrea Endimiani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
分享论文
